ÂÜÀòÂÒÂ×

Asli Aybike Dogan is a highly skilled researcher specializing in bioengineering and health technology, currently serving as a Postdoctoral Researcher at Novo Nordisk, focusing on the development of metabolically functional 3D engineered human skeletal muscle tissue models for Type 2 diabetes. With a strong background in advanced bioprinting and biofabrication techniques, Asli has contributed to multiple research initiatives, including developing physiologically relevant in vitro barrier tissues during a PhD at the Technical University of Denmark, and enhancing communication processes as a Board Member with the Scandinavian Society for Biomaterials. Academic qualifications include a PhD in Health Technology and a Master's degree in Bioengineering from Ege University, complemented by various research roles and internships that have fostered expertise in tissue engineering, molecular analysis, and cell culture.